About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CMV Intensive Care Units | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02324244

CMV Intensive Care Units

Prospectively assessment of CMV viremia by real-time polymerase chain reaction (PCR) in a broad cohort of consecutive immunocompetent adults admitted to a major heart surgery intensive care unit (MHS-...

Lead sponsor: Emilio Bouza•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Emilio Bouza

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Agreeing to participate in the study
•Age of at least 18 years
•Admission to the MHS-ICU for at least 72 hours

Exclusion Criteria

•Inability to give informed consent
•Age younger than 18 years
•AIDS
•Pregnancy
•Organ or bone marrow transplant, receipt of immunosuppressive therapy including corticosteroids within 30 days, and cancer or hematologic malignancy treated with radiotherapy or chemotherapy

Related studies

RECRUITINGPhase 2

Study Evaluating the Efficacy and Safety of Artesunate

NCT06853184 · CMV Infection

TERMINATEDPhase 1

Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells

NCT03798301 · CMV Infection, Cytomegalovirus Infections, and more

Not Yet Recruiting

The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen

NCT06362720 · CMV Infection or Reactivation After Allogenic HSCT

Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit

NCT02680743 · Congenital CMV Infection

Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS

NCT06021210 · CMV Infection, Hematopoietic Stem Cell Transplantation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 24, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment150

Start dateOct 2012

Last updatedDec 24, 2014

Condition

Locations shown

Servicio de Microbiologia y Enfermedades Infecciosas

Madrid, Madrid

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2014Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions